Insurers paid for anti-parasite drug as a treatment for COVID-19 despite lack of evidence surrounding its effectiveness, according to a new study.

Join The Ecosystem

Leave a Reply

Your email address will not be published. Required fields are marked

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}